Simulations mandatory [Two-Stage / GS Designs]

posted by Helmut Homepage – Vienna, Austria, 2024-01-09 10:31 (548 d 05:30 ago) – Posting: # 23824
Views: 8,557

Hi Achievwin,

❝ Thank you for your nice reply.

Welcome.

Just to be clear: Some authors (right now I’m reviewing a manuscript submitted to Stat Med…) believe (‼) that Pocock’s \(\small{\color{Blue}{\alpha_\text{adj}=0.0294}}\) (94.12% CI) is ‘uni­versally’ valid – even for reference-scaling of HVDs. This is a gross misunderstanding and not even wrong. It was derived for superiority testing in a GSD (fixed sample size N) with one interim at – exactly – N/2 and known variances. The fact that it controlled the Type I Error in Pot­vin’s Method B (TSD in a 2×2×2 design) was a mere lucky punch.
In my example I needed \(\small{\color{Red}{\alpha_\text{adj}=0.0274}}\) (94.52% CI) to control the Type I Error.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,682 registered users;
68 visitors (0 registered, 68 guests [including 12 identified bots]).
Forum time: 17:02 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5